Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, previews the Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), cohosted by Florida Cancer Specialists & Research Institute.
The latest advances in personalized care and precision medicine will be addressed at the upcoming in-person Institute for Value-Based Medicine® (IVBM) meeting in Tampa, Florida, said Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute.
Transcript
Can you discuss the theme of the upcoming Tampa IVBM Meeting?
We're so excited to be able to hold that here in Tampa, Florida, but more specifically, closely to where I live in practice in Tampa. We're going to be highlighting several different components that I think are important for everybody to know.
We want everybody to know and understand the advances that we're making with personalized care and personalized medicine, hat does that mean for the patients, how is that accomplished with new advanced testing techniques, and then how that's achieved with new medications. And I think one of the things that we will continue to see, especially as time evolves, the more personalized we can make the medicine, the more effective it will be for the patients, the better outcomes we're going to have. It's going to be a win-win.
Why are in-person meetings important for physicians as we emerge from the pandemic?
That's a very interesting question. In-person meetings are irreplaceable. It allows us to have quick access to some of the most amazing colleagues we will ever have. We can curbside people, we can ask questions, we can stimulate thought, we get ideas—there's a lot of synergy that results very quickly after having an in-person meeting that just cannot be duplicated with virtual meetings.
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More